Literature DB >> 14510657

Prevalence of sensing abnormalities in dual chamber implantable cardioverter defibrillators.

Mohammad Saeed1, Anna Jin, Gregory Pontone, Steve Higgins, Michael Gold, David Harari, Steven Nunley, Mark S Link, Munther K Homoud, N A Mark Estes, Paul J Wang.   

Abstract

BACKGROUND: The clinical efficacy of ICD therapy depends on accurate sensing of intracardiac signals and sensing algorithms. We investigated the occurrence of sensing abnormalities in patients with dual chamber ICDs.
METHODS: The study group consisted of all patients with dual chamber ICDs enrolled in the LESS trial and patients implanted with dual chamber ICDs at a single center between January 1997 and July 2000. Electrograms of spontaneous ventricular arrhythmias requiring device intervention were analyzed.
RESULTS: A total of 48 patients met the criteria for enrollment. Among the 244 episodes, 215 (88%) were due to ventricular tachycardia and 29 (12%) were due to ventricular fibrillation. Overall undersensing was infrequent with 12 (20%) patients exhibiting on average 2.2 undersensed beats during 26 episodes of ventricular arrhythmias. There was no delay in therapy due to undersensing. Oversensing occurred in 5 (10%) patients resulting in 13 (2.7%) episodes of inappropriate therapy. None of the patients had any lead abnormalities and oversensing resolved after device reprogramming in 4 patients while 1 patient required a separate rate sensing lead. Among patients with oversensing, 4 out of 5 were pacing before the index event while among patients with no oversensing only 5 out of 42 were pacing (P<0.001).
CONCLUSIONS: Dual chamber ICDs demonstrate outstanding accuracy of sensing. However, because of the selection of patient population requiring more frequent pacing, oversensing occurs with a significant frequency. Meticulous evaluation in such patients is necessary to minimize the likelihood of oversensing and inappropriate shocks.

Entities:  

Mesh:

Year:  2003        PMID: 14510657      PMCID: PMC6932559          DOI: 10.1046/j.1542-474x.2003.08309.x

Source DB:  PubMed          Journal:  Ann Noninvasive Electrocardiol        ISSN: 1082-720X            Impact factor:   1.468


  20 in total

1.  Spurious redetection of sinus rhythm by an implantable cardioverter defibrillator during spontaneous ventricular fibrillation.

Authors:  L Otto; D E Mann; P A Kelly; M J Reiter
Journal:  Pacing Clin Electrophysiol       Date:  1999-10       Impact factor: 1.976

2.  Inappropriate shocks delivered by implantable cardiac defibrillators during oversensing of activity of diaphagmatic muscle.

Authors:  D Babuty; L Fauchier; P Cosnay
Journal:  Heart       Date:  1999-01       Impact factor: 5.994

3.  Limitations and late complications of third-generation automatic cardioverter-defibrillators.

Authors:  S O Nunain; M Roelke; T Trouton; S Osswald; Y H Kim; G Sosa-Suarez; D R Brooks; B McGovern; M Guy; D F Torchiana
Journal:  Circulation       Date:  1995-04-15       Impact factor: 29.690

4.  Electrophysiologic testing to identify patients with coronary artery disease who are at risk for sudden death. Multicenter Unsustained Tachycardia Trial Investigators.

Authors:  A E Buxton; K L Lee; L DiCarlo; M R Gold; G S Greer; E N Prystowsky; M F O'Toole; A Tang; J D Fisher; J Coromilas; M Talajic; G Hafley
Journal:  N Engl J Med       Date:  2000-06-29       Impact factor: 91.245

5.  Improved survival with an implanted defibrillator in patients with coronary disease at high risk for ventricular arrhythmia. Multicenter Automatic Defibrillator Implantation Trial Investigators.

Authors:  A J Moss; W J Hall; D S Cannom; J P Daubert; S L Higgins; H Klein; J H Levine; S Saksena; A L Waldo; D Wilber; M W Brown; M Heo
Journal:  N Engl J Med       Date:  1996-12-26       Impact factor: 91.245

6.  Undersensing during ventricular tachyarrhythmias in a third-generation implantable cardioverter defibrillator: diagnosis using stored electrograms and correction with programming.

Authors:  D E Mann; P A Kelly; R S Damle; M J Reiter
Journal:  Pacing Clin Electrophysiol       Date:  1994-09       Impact factor: 1.976

7.  A comparison of antiarrhythmic-drug therapy with implantable defibrillators in patients resuscitated from near-fatal ventricular arrhythmias.

Authors: 
Journal:  N Engl J Med       Date:  1997-11-27       Impact factor: 91.245

8.  Oversensing during ventricular pacing in patients with a third-generation implantable cardioverter-defibrillator.

Authors:  P A Kelly; D E Mann; R S Damle; M J Reiter
Journal:  J Am Coll Cardiol       Date:  1994-06       Impact factor: 24.094

9.  Unique sensing errors in third-generation implantable cardioverter-defibrillators.

Authors:  D J Callans; B G Hook; R B Kleiman; R L Mitra; B T Flores; F E Marchlinski
Journal:  J Am Coll Cardiol       Date:  1993-10       Impact factor: 24.094

10.  Indications for dual-chamber (DDD) pacing in implantable cardioverter-defibrillator patients.

Authors:  M Santini; G Ansalone; A Auriti; B Magris; C Pandozi; G Altamura
Journal:  Am J Cardiol       Date:  1996-09-12       Impact factor: 2.778

View more
  2 in total

1.  Chronic lead malposition diagnosis and management: discussion of two cases and literature review.

Authors:  Ahmed Almomani; Amjad Abualsuod; Hakan Paydak; Wilburt Peer; Waddah Maskoun
Journal:  Clin Case Rep       Date:  2017-02-01

2.  Inappropriate Shock delivered by Implantable Cardioverter Defibrillator--Cardiac Resynchronization Therapy (ICD-CRT) due to myopotential oversensing.

Authors:  Hamid Barakpour; Zahra Emkanjoo; Abolfath Alizadeh; Mohammad Ali Sadr-Ameli
Journal:  Indian Pacing Electrophysiol J       Date:  2009-01-07
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.